Oakmont Advisory Group, LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 2115370 ALBUQUERQUE, NM

Position in HALO

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$387,671

+$71,049 QoQ

Shares Held

4,953

+1.1% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.93%

of 13F equity value

Holder Rank

#425

of 664 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Oakmont Advisory Group, LLC holds $853,774 across 5 Biotechnology names. HALO ranks #2 (45.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	7,583	$412,591
2	HALO	Halozyme Therapeutics, Inc. This page	4,953	$387,671
3	INCY	Incyte Corp	461	$52,258
4	REGN	Regeneron Pharmaceuticals, Inc.	2	$1,247
5	VKTX	Viking Therapeutics, Inc.	0	$7

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$387,671	4,953	+1.1%	Shares	Sole	2026-08-03
2026-03-31	$316,622	4,899	—	Shares	Sole	2026-05-12
No filing history on record for this holder in this stock.